In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions.
Category: Diabetes
-
Ozempic Is About to Go Generic in India, China and Canada
The New York Times – Business: -
Sick Detainees Describe Poor Care at CoreCivic ICE Facilities
The New York Times – Business:Problems at detention centers operated by CoreCivic extend far beyond recent measles outbreaks.
-
Eli Lilly, Drug Maker of Zepbound and Mounjaro, Reaches $1 Trillion in Value
The 150-year-old drugmaker is the first company in health care to hit the milestone.
-
Kennedy Walks a Tightrope on Trump Deal for Obesity Drugs
The weight loss medicines are proving to be a test case for Robert F. Kennedy Jr., the health secretary, in straddling divisions between his supporters and the president.
-
A New Barbie Wears Blue Polka-Dots, and a Glucose Monitor
The doll pairs a blue polka-dot outfit with an insulin pump and continuous glucose monitor.
-
Daily Pill May Work as Well as Ozempic for Weight Loss and Blood Sugar
Clinical results of a GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs.
-
Medicare Bleeds Billions on Pricey Bandages, and Doctors Get a Cut
Medicare spending on “skin substitutes” made of dried placenta has soared as doctors pocket lucrative discounts from sellers.
-
FDA Staffed Up to Review AI and Food Safety. Those Hires Are Now Gone.
Teams evaluating high-tech surgical robots and insulin-delivery systems were gutted by Trump layoffs even though industry fees, not taxpayers, financed the employee salaries.
-
Insulin Prices Dropped. But Some Poor Patients Are Paying More.
A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for low-income health clinics.
-
F.D.A. Proposes New Food Labels to Detail Sugar, Fat and Salt Content
The agency issued designs for front-of-package lists that food companies would be required to include.
-
6 Reasons That It’s Hard to Get Your Wegovy and Other Weight-Loss Prescriptions
An array of obstacles make it difficult for patients to obtain Wegovy or Zepbound. Finding Wegovy is “like winning the lottery,” one nurse practitioner said.
-
Thanksgiving Is All About Food. Will Ozempic Make It Better or Worse?
The weight-loss drugs that have swept into the cultural conversation crash into a holiday that’s all about food.